Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification
Autor: | Constance de Margerie-Mellon, Luis Augusto Teixeira, Cédric de Bazelaire, Axelle Dupont, Caroline Cuvier, Sylvie Giacchetti, M. Espie, Jean-Baptiste Debry |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Breast imaging BI-RADS Breast Neoplasms 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Cohen's kappa Biopsy medicine Mammography Humans Radiology Nuclear Medicine and imaging Breast Neuroradiology Retrospective Studies Observer Variation medicine.diagnostic_test business.industry Second opinion Cancer General Medicine medicine.disease 030220 oncology & carcinogenesis Female Radiology Ultrasonography Mammary business |
Zdroj: | European radiology. 31(8) |
ISSN: | 1432-1084 |
Popis: | To compare BI-RADS classification, management, and outcome of nonpalpable breast lesions assessed both by community practices and by a multidisciplinary tumor board (MTB) at a breast unit. All nonpalpable lesions that were first assigned a BI-RADS score by community practices and then reassessed by an MTB at a single breast unit from 2009 to 2017 were retrospectively reviewed. Inter-review agreement was assessed with Cohen’s kappa statistic. Changes in biopsy recommendation were calculated. The percentage of additional tumor lesions detected by the MTB was obtained. The sensitivity, AUC, and cancer rates for BI-RADS category 3, 4, and 5 lesions were computed for both reviews. A total of 1909 nonpalpable lesions in 1732 patients were included. For BI-RADS scores in the whole cohort, a fair agreement was found (κ = 0.40 [0.36–0.45]) between the two reviews. Agreement was higher when considering only mammography combined with ultrasound (κ = 0.53 [0.44–0.62]), masses (κ = 0.50 [0.44–0.56]), and architectural distortion (κ = 0.44 [0.11–0.78]). Changes in biopsy recommendation occurred in 589 cases (31%). Ninety of 345 additional biopsies revealed high-risk or malignant lesions. Overall, the MTB identified 27% additional high-risk and malignant lesions compared to community practices. The BI-RADS classification AUCs for detecting malignant lesions were 0.66 (0.63–0.69) for community practices and 0.76 (0.75–0.78) for the MTB (p |
Databáze: | OpenAIRE |
Externí odkaz: |